Real Economics Needs to Reflect Real Decisions: A Response to Johnson

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.2, 2012-02, pp. : 133-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why Not Real Economics?

By Johnson F. Reed

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 127-131

Adis International

Access to resources Recommend Favorite

Health economics must evolve to reflect patient preference

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Real-World Trials to Answer Real-World Questions

By Freemantle Nick

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 747-754

Adis International

Access to resources Recommend Favorite

Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer

By Fan Alice C O'Rourke Jennifer J Praharaj Dave R Felsher Dean W

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1495-1509

Informa Healthcare

Access to resources Recommend Favorite

Roflumilast a real contender for COPD

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite